The measurement of symptoms, quality of life and sexual function

Donovan, Jenny

doi:10.1046/j.1464-410x.2000.00010.x

Cited by 16 publications

(5 citation statements)

References 62 publications

(132 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The initial assessment involved administering the International Index of Erectile Function (IIEF) [12], a Sexual Function questionnaire [13] and a specifically developed linear pain score questionnaire. An artificial erection was induced using an intracavernosal injection with alprostadil (Caverject, Pharmacia and Upjohn, UK).…”

Section: Methodsmentioning

confidence: 99%

Peyronie's disease—the Plymouth experience of extracorporeal shockwave treatment

et al. 2001

View full text Add to dashboard Cite

Objective To describe our experience of the use of extracorporeal shockwave treatment (EST) for Peyronie's disease. Patients and methods The study included 28 patients (mean age 57 years, range 34±72) with stable Peyronie's disease who were treated with 3.9 (3±5) sessions of EST to the Peyronie's plaque. The patients' erectile function, pain and penile angle were assessed before and after treatment with EST.Results Of the 28 patients, 20 felt that their erection improved after the procedure; 11 patients were able to recommence sexual intercourse and the index of erectile function increased in all but one patient. Conclusion EST produces a signi®cant improvement in pain and penile angle, with no serious complications.

show abstract

Section: Methodsmentioning

confidence: 99%

Peyronie's disease—the Plymouth experience of extracorporeal shockwave treatment

et al. 2001

View full text Add to dashboard Cite

show abstract

“…This can be assessed by a variety of questionnaires among which the QoL question of the IPSS is used most often [3] although more complex instruments such as the SF-36 questionnaire may be more informative [4]. Such research shows that a greater IPSS statistically is strongly associated with a reduced QoL prior to treatment [5, 6].…”

Section: Introductionmentioning

confidence: 99%

Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction

et al. 2009

View full text Add to dashboard Cite

PurposePrevious studies on associations between voiding dysfunction and quality of life (QoL) have largely been limited to baseline data. Therefore, we have explored associations between Qmax and voiding and storage sub-scores of the International Prostate Symptom Score (IPSS) before and after treatment with QoL.MethodsAnalysis of a single-center database of 2,316 men with voiding dysfunction attributed to benign prostatic hyperplasia undergoing various medical and surgical treatment forms.ResultsQmax exhibited little correlation with QoL before or after treatment. IPSS inversely correlated with QoL at baseline and after treatment, and IPSS improvements correlated with those of QoL. The associations applied to both the voiding and storage sub-score of the IPSS, with the latter consistently exhibiting somewhat tighter associations.ConclusionsOur post-treatment data support the idea of a cause–effect relationship between voiding symptoms and QoL irrespective of treatment form. While both voiding and storage symptoms contribute to this relationship, storage symptoms play a somewhat greater role.

show abstract

“…However, information on predicting treatment response at an early stage is limited. Although various questionnaires are used to assess disease condition and QoL in patients with LUTS‐BPH, IPSS is most commonly used in clinical settings . Research suggests that a greater total IPSS is strongly correlated with reduced QoL .…”

Section: Introductionmentioning

confidence: 99%

“…Although various questionnaires are used to assess disease condition and QoL in patients with LUTS-BPH, IPSS is most commonly used in clinical settings. 12 Research suggests that a greater total IPSS is strongly correlated with reduced QoL. 13 Existing studies have shown an association between IPSS and QoL at baseline.…”

Section: Introductionmentioning

confidence: 99%

Early improvement of storage or voiding symptoms by tadalafil predicts treatment outcomes in patients with lower urinary tract symptoms from benign prostatic hyperplasia

et al. 2017

View full text Add to dashboard Cite

show abstract

The measurement of symptoms, quality of life and sexual function

Cited by 16 publications

References 62 publications

Peyronie's disease—the Plymouth experience of extracorporeal shockwave treatment

Peyronie's disease—the Plymouth experience of extracorporeal shockwave treatment

Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction

Early improvement of storage or voiding symptoms by tadalafil predicts treatment outcomes in patients with lower urinary tract symptoms from benign prostatic hyperplasia

Contact Info

Product

Resources

About